Senior Vice President#BR#Global Clinical Development
Anette Oestergaard joined Ferring Pharmaceuticals in July 2018.
She is responsible for all global clinical development activities in Ferring Pharmaceuticals and is a member of the R&D Leadership team (RDLT), the PDCC and is representing the CSO and CMO areas in the IT Committee (ITC).
Prior to joining Ferring Anette has extensive experience in Drug Development from various leadership positions at MC2 Therapeutics, Leo Pharma A/S, Genmab A/S and Pharmexa A/S.
Anette holds an MSc Pharm from Copenhagen University, a Diploma in Pharmaceutical Medicine from the European Centre of Pharmaceutical Medicine in Basel and an Executive MBA from Middlesex University.